Ascendis Pharma A/S (FRA:A71)
Germany · Delayed Price · Currency is EUR 180.00
+3.00 (1.69%)
At close: Jan 2, 2026
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of €10.71 billion as of January 9, 2026. Its market cap has increased by 33.40% in one year.
Market Cap
10.71B
Enterprise Value
10.99B
Revenue
646.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
€180.00
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from 364.37M to 10.71B, an increase of 2,839.71%. That is a compound annual growth rate of 36.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 10.71B | -3.91% |
| Dec 31, 2025 | 11.15B | 40.17% |
| Dec 31, 2024 | 7.95B | 23.38% |
| Dec 29, 2023 | 6.45B | 0.95% |
| Dec 30, 2022 | 6.38B | -4.90% |
| Dec 31, 2021 | 6.71B | -8.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |